Stocktoria

Allogene Therapeutics, Inc. ALLO

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-10-11

Allogene Therapeutics, Inc. statistics & valuation

Market cap$735.2M
P / B2.5×
Return on equity-65.3%
Return on capital-54.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201820192019202020212022202320242025
Operating margin (%)
-157.90% -215087.20% -344986.30% -1241813.60% 201820192019202020212022202320242025
Return on equity (%)
-30.10% -35.70% -29.30% -24.70% -19.70% -51.00% -63.90% -61.00% -65.30% 201820192019202020212022202320242025
Shares outstanding
121.5M 121.5M 124.3M 140.5M 142.6M 144.4M 168.6M 212.2M 229.4M 201820192019202020212022202320242025
Net debt ($)
201820192019202020212022202320242025
Share buybacks ($)
201820192019202020212022202320242025
Return on assets (%)
-27.30% -32.40% -25.70% -20.40% -17.50% -41.40% -50.90% -46.90% -45.90% 201820192019202020212022202320242025
Free cash flow margin (%)
-180.80% -144685.90% -251841.10% -913609.10% 201820192019202020212022202320242025
Debt / equity (×)
201820192019202020212022202320242025
EPS ($)
-$1.83 -$2.08 -$1.34 -$2.38 -$2.09 -$1.32 -$0.87 201820192019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2019FY2018
Operating margin—-1241813.6%-344986.3%-215087.2%-157.9%————
Net margin—-1170863.6%-344489.5%-218214.1%-159.6%————
FCF margin—-913609.1%-251841.1%-144685.9%-180.8%————
Return on assets-45.9%-46.9%-50.9%-41.4%-17.5%-20.4%-25.7%-32.4%-27.3%
Return on equity-65.3%-61.0%-63.9%-51.0%-19.7%-24.7%-29.3%-35.7%-30.1%
Current ratio7.938.5412.389.849.788.9616.4617.4815.89

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.